increased significantly, which completely offset the decline in operating profit of the coatings segment. > Container coatings and industrial heavy-duty anti-corrosion coatings.
China Resources Pharmaceutical plans to acquire 10% equity of Yongtai Biotechnology for HK$800 million
Time of Update: 2021-08-06
Limited, Ren Xiaojuan and BeiNi Ltd (as the seller) ) Entered into a share purchase agreement, pursuant to which the buyer conditionally agreed to purchase and the seller conditionally agreed to sell Wing Tai Biopharmaceutical Co.
Luoxin Pharmaceutical and HK inno.N of South Korea join hands again, aiming at the US$2 billion Chinese PPI injection market
Time of Update: 2021-07-29
N Corporation, we have once again worked together to develop the PPI injection market in China, further consolidating Luo Xin's leading position in the digestion field .
Hong Kong RGC approved HK$400 million to fund eight research projects
Time of Update: 2021-07-29
8 outstanding research proposals have been approved for funding of more than 400 million yuan (Hong Kong dollars, the same below), of which 2 items are related to new coronary pneumonia .
Deck Pharmaceuticals (6996.HK) was included in nine benchmark and thematic indexes including the Hang Seng Composite Index
Time of Update: 2021-07-23
The Hang Seng Southbound Stock Connect Index reflects the overall performance of Hong Kong Main Board-listed securities that can be invested through Southbound Stock Connect channels .
WuXi Biologics major shareholder reduces holdings and cashes in by nearly HK$11.6 billion
Time of Update: 2021-07-01
44%, and it will continue to be the major shareholder of WuXi Biologics .
Simcere Pharmaceuticals (2096.HK): R&D investment continues to increase the concentration of multiple innovative drug INDs
Time of Update: 2021-05-09
the deep water zone, pharmaceutical companies regard innovative R&D as their core development strategy. According to McKinsey's 2018 "Break the Cocoon and Become a Butterfly: Transformation of Chinese Pharmaceutical Companies
Xinda Bio refinanced HK$4.671 billion through the distribution
Time of Update: 2021-03-09
. A distribution is a targeted offering of shares by an H-share listed company to a specific institution. According to the LISTING Rules of hkex, listed companies generally require shareholders to give general authorization to the board of directors through
Ye's Chemical achieved a turnover of HK$3.35 billion in coatings (including inks) in 2014
Time of Update: 2021-03-01
products manufacturers, Yeshi Chemical Group Co., Ltd. (stock number: 00408) ("Ye's Chemical" or "Group") announced its full-year results for the 12 months ended December 31, 2014 (the "Review Period"). review period, continued weakness in global
Li Ka-shing is expected to cash in HK$13.5 billion this month as he accelerates the sale of his property
Time of Update: 2021-02-17
are also aiming for the opportunity to prepare in this bull market. "PeninsulaEast", owned by Defeng (00020.HK), another Hong Kong real estate chamber, is preparing to open, and the company has already offered 256 units, all with varying
Heshengyuan has acquired Australian vitamin manufacturers for nearly HK$8 billion
Time of Update: 2021-02-13
on research, marketing and distribution of vitamins and nutritional supplements under the Swisse brand in Australia and New Zealand. In the first half of this year, the Group's earnings from its continuing operations amounted to HK$1,731 million
HK UNIVERSITY scientists talk about the revelations of the 2016-2017 Hong Kong flu: the pros
Time of Update: 2020-12-14
comparison shows that seasonal influenza in Hong Kong in 2016-2017 was not more severe than in previous years when H3N2 was the main pandemic subtype.
At 02317.HK, net profit for 2019 was up 8.9 per cent at $15.563 million
Time of Update: 2020-11-29
expected during the year, resulting in a decrease in the Group's sales of MSG and seasoning-related products, accounting for 66.0% of the Group's total revenue from 66.0% in 2018 to 65.3%.
Trillions of health giants compete for Ali Health to raise HK$10 billion to add code.
Time of Update: 2020-08-25
trillion big health, BATJH giant to dominate Ali Health aspires to become a collection of pharmaceutical e-commerce, Internet medical, intelligent medical, consumer health care and other business in one, covering the entire health industry integrated medical platform.
Hkust a grant of HK$50 million to set up an AIDS Institute
Time of Update: 2020-07-07
the University of Hong Kong allocated HK$50 million to set up an AIDS Research Institute, which will focus on AIDS vaccines and AIDS pathology.
Dentons Biochemistry: Last year's earnings of HK$9.3 billion gross margin jumped 48%
Time of Update: 2020-07-02
downstream products, including amino acids, corn sweeteners, degenerative starch and biochemical alcohol products, gross margin selling in 2010 was HK$6.372 billion and HK$1,316 million, respectively, up 19% and 71% from 2009.
